NCT06213077

The Effects of a Nitrate Supplementation on Erectile Function

To Determine the Potentiating Effects of Berkeley Life Foundation Nitric Oxide Capsules in Supporting Healthy Sexual Function in Men on an Existing Treatment Plan But Who Are Experiencing Occasional Unsatisfactory Erections.
RHA Investments Ltd·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Erectile Dysfunction
Drug/Device/Intervention
Nitric Oxide
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
RHA Investments Ltd
Location
Charlotte, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 12, 2023
End date
May 30, 2024
Enrollment
20 participants
Primary outcome

International Index of Erectile Function,Erection Hardness Score

Summary

Twenty (20) individuals to be recruited from Ballantyne Medical Associates in Charlotte, NC,
 without any significant chronic medical history. These patients are general patients for
 primary care that meet inclusion criteria. Patients will be screened and enrolled by Dr.
 Bauer and his delegated research staff upon patient consult. Patients will be informed of the
 purpose of the study including risks, benefits, and alternative treatments to the study.
 After the potential participants have been given the opportunity to ask questions and have
 their questions answered, they will be asked to sign an informed consent prior to any
 study-specific procedures being performed.
 
 Blinded test product will be randomly assigned to study subjects. Test group 1 will be dosed
 with a placebo capsule taken two capsules once daily Test group 2 will be dosed with Berkeley
 Life capsules taken two capsules once daily. At baseline, prior to crossover to the other
 treatment, and at the study's conclusion, NO levels will be monitored using salivary nitric
 oxide test strips. Both test groups will remain on their existing treatment protocol
 throughout the study.

ICD-10 classifications
Orgasmic dysfunctionOther disorders of penisOther specified disorders of penisSexual dysfunction, not caused by organic disorder or diseaseTesticular dysfunction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06213077
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06213077 through Pure Global AI's free database. This phase not specified trial is sponsored by RHA Investments Ltd and is currently Recruiting. The study focuses on Erectile Dysfunction. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.